Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins.
Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins.
复制标题
DOI:
10.1186/s13024-018-0275-3
复制
发表时间:
2018-08-02
影响因子:
15.1
通讯作者:
Goodier JL
中科院分区:
文献类型:
--
作者:
Mayer J;Harz C;Sanchez L;Pereira GC;Maldener E;Heras SR;Ostrow LW;Ravits J;Batra R;Meese E;García-Pérez JL;Goodier JL
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder. About 90% of ALS cases are without a known genetic cause. The human endogenous retrovirus multi-copy HERV-K(HML-2) group was recently reported to potentially contribute to neurodegeneration and disease pathogenesis in ALS because of transcriptional upregulation and toxic effects of HML-2 Envelope (Env) protein. Env and other proteins are encoded by some transcriptionally active HML-2 loci. However, more detailed information is required regarding which HML-2 loci are transcribed in ALS, which of their proteins are expressed, and differences between the disease and non-disease states. For brain and spinal cord tissue samples from ALS patients and controls, we identified transcribed HML-2 loci by generating and mapping HML-2-specific cDNA sequences. We predicted expression of HML-2 env gene-derived proteins based on the observed cDNA sequences. Furthermore, we determined overall HML-2 transcript levels by RT-qPCR and investigated presence of HML-2 Env protein in ALS and control tissue samples by Western blotting. We identified 24 different transcribed HML-2 loci. Some of those loci are transcribed at relatively high levels. However, significant differences in HML-2 loci transcriptional activities were not seen when comparing ALS and controls. Likewise, overall HML-2 transcript levels, as determined by RT-qPCR, were not significantly different between ALS and controls. Indeed, we were unable to detect full-length HML-2 Env protein in ALS and control tissue samples despite reasonable sensitivity. Rather our analyses suggest that a number of HML-2 protein variants other than full-length Env may potentially be expressed in ALS patients. Our results expand and refine recent publications on HERV-K(HML-2) and ALS. Some of our results are in conflict with recent findings and call for further specific analyses. Our profiling of HML-2 transcription in ALS opens up the possibility that HML-2 proteins other than canonical full-length Env may have to be considered when studying the role of HML-2 in ALS disease. The online version of this article (10.1186/s13024-018-0275-3) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
4.7
作者:
Agoni L;Guha C;Lenz J
通讯作者:
Lenz J
影响因子:
5.2
作者:
Douville RN;Nath A
通讯作者:
Nath A
影响因子:
3.3
作者:
Fuchs NV;Loewer S;Daley GQ;Izsvák Z;Löwer J;Löwer R
通讯作者:
Löwer R
影响因子:
8
作者:
Boese, A;Sauter, M;Mueller-Lantzsch, N
通讯作者:
Mueller-Lantzsch, N
影响因子:
11.2
作者:
Douville, Renee;Liu, Jiankai;Rothstein, Jeffrey;Nath, Avindra
通讯作者:
Nath, Avindra